Product Description

Duovir-N Tablet is a combination antiretroviral medicine containing Lamivudine, Zidovudine, and Nevirapine. It is used as part of antiretroviral therapy for the treatment of Human Immunodeficiency Virus infection and should be taken under the supervision of a qualified healthcare professional.

🔹 Key Uses
Duovir-N Tablet may be used for:

Treatment of Human Immunodeficiency Virus infection
Reduction of Human Immunodeficiency Virus viral load
Supporting immune system function
Helping slow the progression of Human Immunodeficiency Virus infection
Combination antiretroviral therapy

🔹 Composition
Active ingredients: Lamivudine + Zidovudine + Nevirapine
Medicine class: Combination antiretroviral medicine
Dosage form: Tablet

🔹 How It Works
The three medicines work together to reduce Human Immunodeficiency Virus replication:

Lamivudine interferes with the virus's reverse transcriptase enzyme.
Zidovudine interferes with viral DNA production.
Nevirapine inhibits reverse transcriptase through a different mechanism.

Together, they help suppress viral replication and reduce the amount of Human Immunodeficiency Virus in the blood.

🔹 Key Benefits

Combines three antiretroviral medicines in one tablet
Helps reduce Human Immunodeficiency Virus viral load
Supports immune system function
Helps slow disease progression when taken consistently as prescribed

🔹 Dosage and Administration
The dose and duration are determined by the treating healthcare professional.

Take exactly as prescribed.
Take the tablet consistently at the prescribed times.
Do not miss doses or stop treatment without medical advice.
Regular blood tests may be required to monitor treatment safety and effectiveness.

🔹 Possible Side Effects
Common side effects may include:

Nausea
Headache
Tiredness
Diarrhea
Abdominal discomfort
Rash

Serious side effects can include severe skin reactions, liver problems, and significant reductions in blood cell counts.

🔹 Precautions and Warnings

Nevirapine can cause serious liver and skin reactions, particularly during the early stages of treatment.
Regular liver function and blood count monitoring may be required.
Inform your doctor about liver disease, kidney problems, or previous reactions to antiretroviral medicines.
Tell your doctor about all medicines and supplements you are taking.
Do not stop treatment without medical advice, as this may lead to worsening of the infection or drug resistance.
Seek urgent medical attention for severe rash, blistering, fever, facial swelling, yellowing of the skin or eyes, or severe weakness.